glp-1 effectiveness for weight loss Glucagon-like peptide-1 receptor: mechanisms and advances in therapy GLP-1 Agonists Weight Loss Drugs

Antidepressant use during pregnancy and childhood autism spectrum disorders

Results from the phase 1 human study show weight loss of 14% in 30 days with decreases in glucose, glucagon and C-reactive protein and an acceptable safety profile.48 It allows monthly subcutaneous administration

Skin lightening therapy can treat hyperpigmentation

Alcohol can affect clotting, but it is not a safe or reliable way to prevent clots

Synthesized peptides have been used in medicine as pharmaceuticals for decades, says endocrinologist Rekha Kumar, MD, associate professor of clinical medicine at Weill Cornell Medicine in New York City

Butyrate is produced in the large intestine by microbial fermentations, particularly of dietary fiber, and serves as primary fuel for colonocytes